Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:2282-2290
Published online before print May 2, 2005, doi: 10.1161/01.CIR.0000164262.08004.BB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/18/2282    most recent
01.CIR.0000164262.08004.BBv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korte, T.
Right arrow Articles by Grohé, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korte, T.
Right arrow Articles by Grohé, C.
Related Collections
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Chronic ischemic heart disease

(Circulation. 2005;111:2282-2290.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Female Mice Lacking Estrogen Receptor ß Display Prolonged Ventricular Repolarization and Reduced Ventricular Automaticity After Myocardial Infarction

Thomas Korte, MD; Martin Fuchs, MD; Andreas Arkudas, BS; Sebastian Geertz, BS; Rainer Meyer, PhD; Ajmal Gardiwal, MD; Gunnar Klein, MD; Michael Niehaus, MD; Andrée Krust, PhD; Pierre Chambon, PhD; Helmut Drexler, MD; Klaus Fink, MD; Christian Grohé, MD

From the Department of Cardiology and Angiology, Medical School Hannover, Hannover, Germany (T.K., M.F., A.A., S.G., A.G., G.K., M.N., H.D.); Institute of Physiology (R.M.), Institute of Pharmacology and Toxicology (K.F.), and Medizinische University Poliklinik (C.G.), University of Bonn, Bonn, Germany; and Institute de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP/, Collège de France, Illkirch, CU de Strasbourg, France (A.K., P.C.).

Correspondence to Thomas Korte, MD, Department of Cardiology and Angiology, Medical School Hannover, Carl-Neuberg Strasse 1, 30625 Hannover, Germany. E-mail korte.thomas{at}mh-hannover.de

Received September 21, 2004; revision received December 9, 2004; accepted December 29, 2004.

Background— Major gender-based differences in the incidence of ventricular tachyarrhythmia after myocardial infarction have been shown in humans. Although the underlying mechanisms are unclear, earlier studies suggest that estrogen receptor–mediated effects play a major role in this process.

Methods and Results— We examined the effect of estrogen receptor {alpha} (ER{alpha}) and estrogen receptor ß (ERß) on the electrophysiological phenotype in female mice with and without chronic anterior myocardial infarction. There was no significant difference in overall mortality, infarct size, and parameters of left ventricular remodeling when we compared infarcted ER{alpha}-deficient and ERß-deficient mice with infarcted wild-type animals. In the 12-hour telemetric ECG recording 6 weeks after myocardial infarction, surface ECG parameters did not show significant differences in comparisons of ER{alpha}-deficient mice versus wild-type controls, infarcted versus noninfarcted ER{alpha}-deficient mice, and infarcted ER{alpha}-deficient versus infarcted wild-type mice. However, infarcted ERß-deficient versus noninfarcted ERß-deficient mice showed a significant prolongation of the QT (61±6 versus 48±8 ms; P<0.05) and QTc intervals (61±7 versus 51±9 ms; P<0.05) and the JT (42±6 versus 31±4 ms; P<0.05) and JTc intervals (42±7 versus 33±4 ms; P<0.05). Furthermore, infarcted ERß-deficient versus infarcted wild-type mice showed a significant prolongation of the QT (61±6 versus 53±8 ms; P<0.05) and QTc intervals (61±7 versus 53±7 ms; P<0.05) and the JT (42±6 versus 31±5 ms; P<0.05) and JTc intervals (42±7 versus 31±5 ms; P<0.05), accompanied by a significant decrease of ventricular premature beats (7±21/h versus 71±110/h; P<0.05). Finally, real-time polymerase chain reaction–based quantitative analysis of mRNA levels showed a significantly lower expression of Kv4.3 (coding for Ito) in ERß-deficient mice (P<0.05).

Conclusions— Estrogen receptor ß deficiency results in prolonged ventricular repolarization and decreased ventricular automaticity in female mice with chronic myocardial infarction.


Key Words: estrogens • receptors • mice • myocardial infarction • arrhythmia




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Wang, Y. Wang, B. Weil, A. Abarbanell, J. Herrmann, J. Tan, M. Kelly, and D. R. Meldrum
Estrogen receptor {beta} mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R972 - R978.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. M. Shioura, D. L. Geenen, and P. H. Goldspink
Sex-related changes in cardiac function following myocardial infarction in mice
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R528 - R534.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Domingues-Montanari, I. Subirana, M. Tomas, J. Marrugat, and M. Senti
Association between ESR2 Genetic Variants and Risk of Myocardial Infarction
Clin. Chem., July 1, 2008; 54(7): 1183 - 1189.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T.-M. Lee, M.-S. Lin, and N.-C. Chang
Physiological Concentration of 17{beta}-Estradiol on Sympathetic Reinnervation in Ovariectomized Infarcted Rats
Endocrinology, March 1, 2008; 149(3): 1205 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Jazbutyte, P. A. Arias-Loza, K. Hu, J. Widder, V. Govindaraj, C. von Poser-Klein, J. Bauersachs, K.-H. Fritzemeier, C. Hegele-Hartung, L. Neyses, et al.
Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats
Cardiovasc Res, March 1, 2008; 77(4): 774 - 781.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. A. Babiker, D. Lips, R. Meyer, E. Delvaux, P. Zandberg, B. Janssen, G. van Eys, C. Grohe, and P. A. Doevendans
Estrogen Receptor {beta} Protects the Murine Heart Against Left Ventricular Hypertrophy
Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1524 - 1530.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. S. Karagueuzian, T. Korte, M. Fuchs, A. Arkudas, S. Geertz, A. Gardiwal, G. Klein, M. Niehaus, H. Drexler, R. Meyer, et al.
Letter Regarding Article by Korte et al, "Female Mice Lacking Estrogen Receptor {beta} Display Prolonged Ventricular Repolarization and Reduced Ventricular Automaticity After Myocardial Infarction" * Response
Circulation, October 18, 2005; 112(16): e272 - e272.
[Full Text] [PDF]